Notably, previous reports demonstrated that highly expressed CD56 in ameloblastoma suppressed the migration of ameloblastoma cells, whereas CD56 knockdown impede the proliferation, migration and epithelial-to-mesenchymal transition (EMT) of human melanoma cells, but enhance their apoptosis and autophagy [10, 11]. Here, NCAM1 is linked to ameloblastoma.